Comparison Between Endoscopic Macroscopic Classification and F-18 FDG PET Findings in Gastric Mucosa–Associated Lymphoid Tissue Lymphoma Patients

Purpose: The aim of this study was to compare endoscopic macroscopic classification with fluorine-18 fluorodeoxyglucose (F-18 FDG) uptake in gastric mucosa-associated lymphoid tissue (MALT) lymphoma and to investigate the usefulness of F-18 FDG positron emission tomography (PET) for diagnosing gastric MALT lymphoma. Materials and Methods: Sixteen patients with gastric MALT lymphoma who underwent F-18 FDG PET and gastrointestinal imaging modalities were included in this study. Sixteen healthy asymptomatic participants undergoing both F-18 FDG PET and endoscopy for cancer screening were in the control group. We investigated the difference of F-18 FDG uptake between the gastric MALT lymphoma and the control group and compared the uptake pattern in gastric MALT lymphoma with our macroscopic classification. Results: The endoscopic findings of 16 gastric MALT lymphoma patients were classified macroscopically as chronic gastritis–like tumors (n = 6), depressed tumors (n = 5), and protruding tumors (n = 5). Abnormal gastric F-18 FDG uptake was observed in 63% of tumors in the gastric MALT lymphoma group and 50% of cases in the control group. The median maximum standardized uptake values for gastric MALT lymphoma patients and control group were 4.0 and 2.6, respectively, the difference of which was statistically significant (P = 0.003). F-18 FDG uptake results were positive for all protruding tumors but only 50% for chronic gastritis–like tumors and 40% for depressed-type tumors. Conclusions: F-18 FDG PET may be a useful method for evaluating protrusion-type gastric MALT lymphoma. When strong focal or diffuse F-18 FDG uptake is detected in the stomach, endoscopic biopsy should be performed, even if the endoscopic finding is chronic gastritis.

[1]  J. Trotman,et al.  Role of early PET in the management of diffuse large B-cell lymphoma , 2010, Current opinion in oncology.

[2]  R. Tsang,et al.  Long‐term outcome in localized extranodal mucosa‐associated lymphoid tissue lymphomas treated with radiotherapy , 2010, Cancer.

[3]  Ora Israel,et al.  18F-FDG Avidity in Lymphoma Readdressed: A Study of 766 Patients , 2010, Journal of Nuclear Medicine.

[4]  R. Fujita,et al.  Significance of 18F-2-deoxy-2-fluoro-glucose accumulation in the stomach on positron emission tomography , 2009, Annals of nuclear medicine.

[5]  J. Hatazawa,et al.  Mucosa-associated lymphoid tissue lymphoma studied with FDG-PET: a comparison with CT and endoscopic findings , 2008, Annals of nuclear medicine.

[6]  D. Fischer,et al.  FDG avidity and PET/CT patterns in primary gastric lymphoma , 2008, European Journal of Nuclear Medicine and Molecular Imaging.

[7]  A. Chott,et al.  Pathology and clinical course of MALT lymphoma with plasmacytic differentiation. , 2007, Annals of oncology : official journal of the European Society for Medical Oncology.

[8]  O. Bairey,et al.  Diagnostic accuracy of PET/CT in patients with extranodal marginal zone MALT lymphoma , 2007, European journal of haematology.

[9]  Sigrid Stroobants,et al.  Revised response criteria for malignant lymphoma. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  A. Chott,et al.  18F-Fluoro-deoxy-glucose positron emission tomography in lymphoma of mucosa-associated lymphoid tissue: histology makes the difference. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

[11]  Te-Chun Hsieh,et al.  Positive Correlation Between Standardized Uptake Values of FDG Uptake in the Stomach and the Value of the C-13 Urea Breath Test , 2006, Clinical nuclear medicine.

[12]  U. Jaeger,et al.  18F-fluoro-deoxy-glucose positron emission tomography (18F-FDG-PET) visualizes follicular lymphoma irrespective of grading. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

[13]  T. Akamatsu,et al.  Comparison of Localized Gastric Mucosa‐Associated Lymphoid Tissue (MALT) Lymphoma with and without Helicobacter pylori Infection , 2006, Helicobacter.

[14]  S. Faria,et al.  Lymphomatous involvement of gastrointestinal tract: evaluation by positron emission tomography with (18)F-fluorodeoxyglucose. , 2005, World journal of gastroenterology.

[15]  Y. Erdi,et al.  Intensity of 18fluorodeoxyglucose uptake in positron emission tomography distinguishes between indolent and aggressive non-Hodgkin's lymphoma. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  U. Jaeger,et al.  High Relapse Rate in Patients with MALT Lymphoma Warrants Lifelong Follow-up , 2005, Clinical Cancer Research.

[17]  K. Beal,et al.  FDG-PET scanning for detection and staging of extranodal marginal zone lymphomas of the MALT type: a report of 42 cases. , 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

[18]  M. Seto,et al.  Gastric low-grade B-cell MALT lymphoma: treatment, response, and genetic alteration , 2003, Journal of gastroenterology.

[19]  A. Alavi,et al.  Utility of FDG-PET scanning in lymphoma by WHO classification. , 2003, Blood.

[20]  R. Hustinx,et al.  Positron emission tomography (PET) with 18F-fluorodeoxyglucose (18F-FDG) for the staging of low-grade non-Hodgkin's lymphoma (NHL). , 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

[21]  M E Phelps,et al.  Whole-body FDG-PET imaging for staging of Hodgkin's disease and lymphoma. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[22]  B. Coiffier,et al.  Report on a workshop convened to discuss the pathological and staging classifications of gastrointestinal tract lymphoma. , 1994, Annals of oncology : official journal of the European Society for Medical Oncology.

[23]  A. Hart,et al.  The clinical spectrum and treatment of primary non-Hodgkin's lymphoma of the stomach. , 1993, Annals of oncology : official journal of the European Society for Medical Oncology.

[24]  T. Radaszkiewicz,et al.  Gastrointestinal malignant lymphomas of the mucosa-associated lymphoid tissue: factors relevant to prognosis. , 1992, Gastroenterology.

[25]  P. Isaacson,et al.  Malignant lymphoma of mucosa‐associated lymphoid tissue. A distinctive type of B‐cell lymphoma , 1983, Cancer.

[26]  L. Medeiros,et al.  Extranodal Marginal Zone B-Cell Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT Lymphoma) , 2013 .

[27]  M. Kojima,et al.  The usefulness of 18F‐fluorodeoxyglucose positron emission tomography (18F‐FDG‐PET) and a comparison of 18F‐FDG‐pet with 67gallium scintigraphy in the evaluation of lymphoma , 2022 .